ARCHIVES

Aranesp Improved Anemia In MDS In Phase II Trial

This article is from The Cancer Letter archive.

Vol. 28 No. 9 | September 30, 2005

Download PDF Visit The Full Archive

Related Articles

ACS Board allocated $37.5 Million to Research; More Coming

February 20, 1987

Pharmaceutical Industry: IVAX Official Broder Objects To Orphan Drug Policies of FDA

May 9, 1997

Workshop Suggests Confirmation of Vitamin C Studies

December 7, 1990

HRSA: Discounts Owed on Some Orphan Drug Uses

October 24, 2014

“Confidential and Proprietary” Document Proposes Plan for National Network

February 7, 2014

SWOG Phase III Trial To Test Treatment For Inoperable, Locally Advanced NSCLC

September 28, 2001